cobalt has been researched along with mersalyl in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cove, DH; Crawford, N; Harris, GL | 1 |
| Agani, F; Semenza, GL | 1 |
2 other study(ies) available for cobalt and mersalyl
| Article | Year |
|---|---|
Effect of divalent cations and chelating agents on the ATPase activity of platelet contractile protein, "thrombosthenin".
Topics: Adenosine Triphosphatases; Animals; Barium; Beryllium; Blood Platelets; Blood Proteins; Cadmium; Calcium; Cations, Divalent; Chelating Agents; Cobalt; Edetic Acid; Enzyme Activation; Kinetics; Magnesium; Manganese; Mersalyl; Osmolar Concentration; Strontium; Swine; Time Factors; Zinc | 1974 |
Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity.
Topics: Animals; Antimutagenic Agents; Base Sequence; Cell Hypoxia; Chelating Agents; Cobalt; Deferoxamine; DNA; DNA-Binding Proteins; Endothelial Growth Factors; Enzyme Inhibitors; Erythropoietin; Fibroblasts; Gene Expression Regulation, Neoplastic; Hepatoblastoma; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Lymphokines; Mersalyl; Nuclear Proteins; Phosphopyruvate Hydratase; Rats; Receptor, IGF Type 1; RNA, Messenger; Transcription Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |